Trademark: 97668826
Word
RALLION
Status Date
Friday, August 2, 2024
Filing Date
Tuesday, November 8, 2022
Published for Opposition
Tuesday, December 19, 2023
5 Vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, medical, biological and pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viral diseases and respiratory disorders; mRNA-based therapeutics in the nature of therapeutic agents and therapeutic agents for use in vivo, ex vivo, or in situ for the prevention and treatment of viruses and respiratory disorders; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations for intracellular delivery of self-amplifying messenger RNA (sa-mRNA) for preventing and treating viral diseases all for pharmaceutical, medical or medical diagnostic purposes; drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations; pharmaceutical preparations, namely, messenger RNA (mRNA) therapeutic agents and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells
1 Active biological ingredients for use in the manufacture of pharmaceuticals, namely, self-amplifying messenger RNA (sa-mRNA) encapsulated in a lipid nanoparticle composed of a cationic lipid and three helper lipids for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viruses and respiratory disorders; biochemicals for in vivo, ex vivo, on vivo or in vitro scientific research; biochemicals for medical research for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; lipid nanoparticles for scientific, laboratory or medical research use
44 Medical services; medical information; providing a website featuring medical information
42 Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
Nov 11, 2022
New Application Entered
Nov 29, 2022
New Application Office Supplied Data Entered
Dec 15, 2022
Teas Voluntary Amendment Received
Feb 21, 2023
Assigned To Lie
Feb 22, 2023
Preliminary/Voluntary Amendment - Entered
May 15, 2023
Assigned To Examiner
May 22, 2023
Non-Final Action Written
May 22, 2023
Non-Final Action E-Mailed
May 22, 2023
Notification Of Non-Final Action E-Mailed
Aug 16, 2023
Application Extension To Response Period - Received
Aug 16, 2023
Application Extension Granted/Receipt Provided
Nov 13, 2023
Teas Response To Office Action Received
Nov 13, 2023
Correspondence Received In Law Office
Nov 14, 2023
Teas/Email Correspondence Entered
Nov 15, 2023
Approved For Pub - Principal Register
Nov 29, 2023
Notification Of Notice Of Publication E-Mailed
Dec 19, 2023
Published For Opposition
Dec 19, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 13, 2024
Noa E-Mailed - Sou Required From Applicant
Aug 2, 2024
Sou Teas Extension Received
Aug 2, 2024
Notice Of Approval Of Extension Request E-Mailed
Aug 2, 2024
Sou Extension 1 Granted
Aug 2, 2024
Sou Extension 1 Filed
Trademark Alertz updated from USPTO on 2030-01-24
